Mayne Pharma reports $383.7M in annual revenue
Mayne Pharma (ASX:MYX) reported $86.5 million in fourth-quarter revenue and $383.7 million in full-year revenue for fiscal year 2026.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Mayne Pharma (ASX:MYX) reported $86.5 million in fourth-quarter revenue and $383.7 million in full-year revenue for fiscal year 2026.
China Business Journal said fraudsters impersonated its journalists and demanded Bitcoin (CRYPTO:BTC) from companies by threatening to publish negative reports if payments were not made.
Monadelphous Group (ASX:MND) secured an approximate $165 million contract with Rio Tinto (ASX:RIO) for design and construction.
Crimson Consulting Australia submitted an all-cash takeover proposal valued at approximately $38.6 million for Kip McGrath Education Centres (ASX:KME)
Ferrari (NYSE:RACE) reported second-quarter 2026 revenue of €1.94 billion, up 8% year over year, as demand for personalizations and special models supported results.
Bristol Myers Squibb (NYSE:BMY) reported second-quarter 2026 revenues of $13.0 billion, representing a 6% increase from the prior year.
JLL (NYSE:JLL) reported record second-quarter 2026 revenue of $6.93 billion, up 11% in U.S. dollars and 10% in local currency.
Xenia Hotels & Resorts (NYSE:XHR) announced its second-quarter 2026 financial results, posting a net loss of $19.3 million primarily driven by a property impairment charge.
Titan International (NYSE:TWI) reported a 5.2% year-over-year increase in second-quarter 2026 revenues to $484 million.
Group 1 Automotive (NYSE:GPI) reported second-quarter 2026 revenue of $5.4 billion, down 5.6% year over year, as lower vehicle volumes and finance-related revenue reduced results.